Among them, anti-PD-1 or anti-PD-L1 antibodies have altered the treatment of advanced cancers, such as melanoma [28, 29], lung cancer [30], kidney cancer [31], or various others [32, 33]. This evidence concerns the gene CD274 and cancer.